August 22, 2018
Via: Mass DeviceBrainsWay said it has won de novo clearance from the FDA for its deep transcranial magnetic stimulation (Deep TMS) system for treatment of obsessive-compulsive disorder (OCD) in adults. The clearance marks the second indication granted for BrainsWay Deep TMS, and […]
April 11, 2024
March 28, 2024
March 27, 2024
March 29, 2024
April 2, 2024
April 3, 2024